Recent Progress: Gynecologic Oncology Group Trials in Uterine Corpus Tumors
Louise P. King and David Scott Miller
Affiliation: Director and Dallas Foundation Chair in Gynecologic Oncology, Professor of Obstetrics&Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., J7.124, Dallas, TX 75390-9032.
Keywords: Gynecology oncology group, endometrial cancer, carcinosarcoma, gestational trophoblastic neoplasia, clinical trials
The Gynecologic Oncology Group (GOG) has conducted multiple trials related to neoplasms of the uterine corpus. Recently, several of these trials have been presented and/or published. Areas of focus included the feasibility of laparoscopic staging for endometrial cancer, the adjuvant management of locally advanced endometrial cancer, whole abdominal irradiation in maximally resected advanced endometrial carcinoma, and combination chemotherapy regimens for stage I and II carcinosarcoma after primary surgery and for advanced or recurrent carcinosarcoma. This article will discuss the background and details of each of these important advances.
Rights & PermissionsPrintExport